Clinical trialNCT06119581RecruitingPhase 3Interventional

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

SponsorEli Lilly and CompanyEnrollment1,264Carcinoma, Non-Small-Cell LungNeoplasm Metastasis

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

419 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Royal Adelaide Hospital
Adelaide, Australia
Harminder Takhar
Recruiting
Icon Cancer Centre Wesley
Auchenflower, Australia
Adam Stirling
Recruiting
Ballarat Health Services
Ballarat Central, Australia
Wasek Faisal
Recruiting
Sunshine Coast University Hospital
Birtinya, Australia
Bryan Chan
Recruiting
Gosford Hospital
Gosford, Australia
Matthew Ho Fai Wong
Recruiting
Mackay Base Hospital
Mackay, Australia
Nimisha Kumari
Recruiting
St Vincent'S Hospital
Melbourne, Australia
Melissa Moore
Recruiting
Sir Charles Gairdner Hospital
Perth, Australia
samantha bowyer
Recruiting
Goulburn Valley Health
Shepparton, Australia
Myron Klevansky
Recruiting
Gold Coast University Hospital
Southport, Australia
Robert Mason
Recruiting
the Townsville Hospital
Townsville, Australia
Abhishek Joshi
Recruiting

Austria

Landeskrankenhaus Feldkirch
Feldkirch, Austria
Thomas Winder
Recruiting
Ordensklinikum Linz Gmbh Elisabethinen
Linz, Austria
Michael Schumacher
Recruiting
Klinik Floridsdorf
Vienna, Austria
Maximilian Hochmair
Recruiting

Belgium

Zna Middelheim
Antwerp, Belgium
Kim De Muynck
Recruiting
Chirec - Site Delta
Auderghem, Belgium
Christophe Compère
Recruiting
Az Sint-Jan Brugge-Oostende Av
Bruges, Belgium
Lander Van Acker
Recruiting
Uz Gent
Ghent, Belgium
Veerle Surmont
Recruiting
Az Groeninge Campus Kennedylaan
Kortrijk, Belgium
Katrien Ghysen
Recruiting
Uz Leuven
Leuven, Belgium
christophe Dooms
Recruiting
Az Sint-Maarten
Mechelen, Belgium
Marc Lambrechts
Recruiting
Clinique Saint Pierre
Ottignies, Belgium
Luciano Carestia
Recruiting
Az Glorieux Ronse
Ronse, Belgium
Patrick Alexander
Recruiting
Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godinne
Yvoir, Belgium
Sebahat Ocak
Recruiting

Brazil

Fundação Pio Xii - Hospital de Câncer de Barretos
Barretos, Brazil
Carlos Baston silva
Recruiting
Hospital Tacchini
Bento Gonçalves, Brazil
ANDRE REIRIZ
Recruiting
Hospital São Domingos
Bequimão, Brazil
Antonio Alencar
Recruiting
Sirio-Libanes Brasilia - Centro de Oncologia - Asa Sul
Brasília, Brazil
Rafaela Ribeiro
Recruiting
Hospital Universitário Evangélico Mackenzie
Curitiba, Brazil
Fernanda Ronchi
Recruiting
Centro de Pesquisa Clínica Do Instituto Do Câncer Do Ceará
Fortaleza, Brazil
Fabio Chaves
Recruiting
Oncosite - Centro de Pesquisa Clinica Em Oncologia
Ijuí, Brazil
Fabio Franke
Recruiting
Hospital Brasilia
Lago Sul, Brazil
Fernanda Amorim
Recruiting
Hospital de Cancer de Londrina
Londrina, Brazil
Mariana Piovesana
Recruiting
Liga Norte Riograndense Contra O Câncer
Natal, Brazil
Sulene Oliveira
Recruiting
Hospital São Lucas Da Pucrs
Porto Alegre, Brazil
Ana Caroline Gelatti
Recruiting
Oncominas
Pouso Alegre, Brazil
Marina Zorzetto
Recruiting
Centro de Tratamento de Tumores Botafogo Para Oncoclinicas Rio de Janeiro Sa
Rio de Janeiro, Brazil
Tatiane Montella
Recruiting
Instituto D'Or Pesquisa E Ensino
Rio de Janeiro, Brazil
Clarissa Serodio da Rocha Baldotto
Recruiting
Instituto Nacional de Câncer José Alencar Gomes Da Silva - Inca
Rio de Janeiro, Brazil
Victor Santos
Recruiting
Clinica Amo - Rio Vermelho
Salvador, Brazil
Aknar Calabrich
Recruiting

379 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Carboplatin →Cisplatin →OlomorasibPembrolizumab →Pemetrexed →Placebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 21 Dec 2023
Primary completion: 30 Nov 2027
Completion: 31 Jan 2031
Last update posted: 7 Jul 2026
Registered enrollment: 1,264
Registry id: NCT06119581

Cross-registrations

EU-CTR / CTIS (EudraCT)2023-503412-33-00

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.